Bronchiolitis Obliterans
Symptoms, Doctors, Treatments, Advances & More

Bronchiolitis Obliterans Overview

Save information for later
Sign Up

Learn About Bronchiolitis Obliterans

What is the definition of Bronchiolitis Obliterans?
Bronchiolitis obliterans is an inflammatory condition that affects the lung's tiniest airways, the bronchioles. In affected people, the bronchioles may become damaged and inflamed leading to extensive scarring that blocks the airways. Symptoms of the condition include a dry cough; shortness of breath; and/or fatigue and wheezing in the absence of a cold or asthma. Many different chemicals (such as nitrogen oxides, ammonia, welding fumes or food flavoring fumes) and respiratory infections can cause lung injury that leads to Bronchiolitis obliterans. It can also be associated with rheumatoid arthritis and graft-versus-host disease following a lung or hematopoietic cell transplantation. Another similarly named disease, Bronchiolitis obliterans organizing pneumonia, is a different disease.
What are the alternative names for Bronchiolitis Obliterans?
  • Bronchiolitis obliterans
  • Obliterative bronchiolitis
Who are the top Bronchiolitis Obliterans Local Doctors?
Vibha N. Lama
Elite in Bronchiolitis Obliterans
Dr. Vibha N. Lama
Intensive Care Medicine
Elite in Bronchiolitis Obliterans
Dr. Vibha N. Lama
Intensive Care Medicine

Emory University Hospital

1364 Clifton Road Northeast, 
Atlanta, GA 
404-712-2000
Experience:
34+ years
Languages Spoken:
English
See accepted insurances

Vibha Lama is an Intensive Care Medicine provider in Atlanta, Georgia. Dr. Lama has been practicing medicine for over 34 years and is rated as an Elite provider by MediFind in the treatment of Bronchiolitis Obliterans. Her top areas of expertise are Bronchiolitis Obliterans, Bronchitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Lung Transplant.

Elite in Bronchiolitis Obliterans
Dr. Guang-shing Cheng
Cardiology | Pulmonary Medicine
Elite in Bronchiolitis Obliterans
Dr. Guang-shing Cheng
Cardiology | Pulmonary Medicine

Gme Office University Of Washington

1959 NE Pacific St, 
Seattle, WA 
206-598-4615
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Guang-shing Cheng is a Cardiologist and a Pulmonary Medicine provider in Seattle, Washington. Dr. Cheng is rated as an Elite provider by MediFind in the treatment of Bronchiolitis Obliterans. Her top areas of expertise are Bronchiolitis Obliterans, Chronic Graft Versus Host Disease (cGvHD), Bronchitis, Lung Transplant, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Bronchiolitis Obliterans
Dr. Joe Hsu
Intensive Care Medicine
Elite in Bronchiolitis Obliterans
Dr. Joe Hsu
Intensive Care Medicine

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
650-725-7061
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joe Hsu is an Intensive Care Medicine provider in Stanford, California. Dr. Hsu is rated as an Elite provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Bronchiolitis Obliterans, Chronic Graft Versus Host Disease (cGvHD), Aspergillosis, Allergic Bronchopulmonary Aspergillosis, and Lung Transplant.

View All Doctors
What are the latest Bronchiolitis Obliterans Clinical Trials?
An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation
An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation
Enrollment Status: Recruiting
Publish Date: February 11, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: The goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT) recipients who have been newly diagnosed or have developing (early stage) bronchiolitis obliterans syndrome (BOS). The name of the study drugs involved in this study are: * Belumosudil (an immunotherapy) * Fluticasone (an intranasal cortic...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Exploratory Study of Airway Basal Stem Cells on Treatment of Pediatric Bronchiolitis Obliterans
Exploratory Study of Airway Basal Stem Cells on Treatment of Pediatric Bronchiolitis Obliterans
Enrollment Status: Recruiting
Publish Date: January 14, 2026
Intervention Type: Biological
Study Phase: Early Phase 1

Summary: Bronchiolitis obliterans (BO) is a chronic lung disease which was initiated with injury of the bronchiolar epithelium and resulted in nonuniform luminal obliteration or narrowing. Among children, the most common form of BO is post-infectious BO with a lack of treatment guidelines or standard therapy. In this study, an open, single-armed study is performed to preliminarily evaluate the safety and e...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center